What is Danusertib used for?

Danusertib is being studied as a treatment for prostate cancer, multiple myeloma, and leukemia.

Is Danusertib FDA approved?

No, Danusertib is currently in Phase 2 clinical trials and is not yet approved for medical use.

What kind of cancer can Danusertib treat?

Research is looking into how Danusertib might help with prostate cancer, leukemia, and multiple myeloma.

What stage of testing is Danusertib in?

Danusertib is currently in Phase 2 of clinical testing.

Is Danusertib a small molecule drug?

Yes, Danusertib is classified as a small molecule.

What are the target areas for Danusertib?

The drug has been shown to interact with 337 different targets in laboratory studies.

danusertib | CAS 827318-97-8 | XKFTZKGMDDZMJI

Loading compound...

Small molecule cancer research drug

Danusertib is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential to treat certain types of cancer, including prostate cancer, multiple myeloma, and leukemia.

How it worksDanusertib is a small molecule designed to target specific biological pathways involved in cancer cell growth.

Used for

Prostate cancerMultiple myelomaLeukemia

Conditions

Prostate cancerMultiple myelomaLeukemia

Class

Small moleculeSmall molecule cancer research drugHematologicEndocrine

How to take

This drug is currently in clinical development phases (Phase 2) and is not yet approved for general use by the FDA.

Talk to your doctor

Questions to ask

·Is Danusertib part of a clinical trial I can join?
·How does Danusertib target cancer cells?
·What are the expected risks of Danusertib?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)